| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.089 | 0.007 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.008 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.008 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.097 | 0.008 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.008 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.009 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.3 | 0.01 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.36 | 0.01 |